Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study.

The XEN-GGM resulted in lower IOP and a reduction in medications from baseline over 4 years of follow-up. There was no detectable decrease in visual fields over the study. The surgical failure rate is comparable to other filtration surgeries.